Rosenberg Nahum

Rosenberg Nahum


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
SSShalom Stahl
Shalom Stahl
IKIris Karsh-Zafrir
Iris Karsh-Zafrir
NRNavah Ratzon
Navah Ratzon
RNRosenberg Nahum
Rosenberg Nahum
Trapeziometacarpal joint arthritis is a disabling condition presenting with pain at the base of the thumb causing impairment of hand function. Nonoperative treatment at an early stage includes intraarticular steroid injection. Although this treatment may bring about prompt symptomatic relief, its efficacy is unpredictable. There is previous evidence that injection of sodium hyaluronate is effective and safe in the treatment of knee arthritis. We proposed that intraarticular injection of sodium hyaluronate, for the symptomatic treatment of trapeziometacarpal joint arthritis, could provide symptomatic relief without the adverse effects of steroids. Fifty-two patients with trapeziometacarpal joint grade II arthritis were randomized prospectively either for methylprednisolone or hyaluronate intraarticular injections. Initial evaluation included an estimation of pain, grip, pinch strengths and the functional Purdue Pegboard Test (PPT). This evaluation was repeated after 1, 3, and 6 months and statistically compared with the initial evaluation. In both groups, the intraarticular injection produced a relief of pain after 1 month. Grip strength improved significantly in the group treated by the steroid during the whole evaluation period. The patients treated by hyaluronate showed improvement in grip strength after 6 months and in the pinch and the PPT after 3 months. Steroids and hyaluronate injections were found effective in reducing pain. Hyaluronate was more effective in the improvement of some aspects of fine hand function.

1 December 1995 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
RSR. Schneiderman
R. Schneiderman
RNRosenberg Nahum
Rosenberg Nahum
JJJ. J.Hisscd
J. J.Hisscd
PPP. P.Leecd
P. P.Leecd
FLF. Liu
F. Liu
AMA. Maroudas
A. Maroudas

29 April 2012 in Rambam Maimonides Medical Journal
Verified
Journal Article
Open access
RNRosenberg Nahum
Rosenberg Nahum
OROrit Rosenberg
Orit Rosenberg
MSMichael Soudry
Michael Soudry
Bone structural integrity and shape are maintained by removal of old matrix by osteoclasts and in-situ synthesis of new bone by osteoblasts. These cells comprise the basic multicellular unit (BMU). Bone mass maintenance is determined by the net anabolic activity of the BMU, when the matrix elaboration of the osteoblasts equals or exceeds the bone resorption by the osteoclasts. The normal function of the BMU causes a continuous remodeling process of the bone, with deposition of bony matrix (osteoid) along the vectors of the generated force by gravity and attached muscle activity. The osteoblasts are derived from mesenchymal stem cells (MSCs). Circulating hormones and locally produced cytokines and growth factors modulate the replication and differentiation of osteoclast and osteoblast progenitors. The appropriate number of the osteoblasts in the BMU is determined by the differentiation of the precursor bone-marrow stem cells into mature osteoblasts, their proliferation with subsequent maturation into metabolically active osteocytes, and osteoblast degradation by apoptosis. Thus, the two crucial points to target when planning to control the osteoblast population are the processes of cell proliferation and apoptosis, which are regulated by cellular hedgehog and Wnt pathways that involve humoral and mechanical stimulations. Osteoblasts regulate both bone matrix synthesis and mineralization directly by their own synthetic activities, and bone resorption indirectly by its paracrinic effects on osteoclasts. The overall synthetic and regulatory activities of osteoblasts govern bone tissue integrity and shape.

1 September 2007 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
RNRosenberg Nahum
Rosenberg Nahum
LNLars Neumann
Lars Neumann
AWAngus W. Wallace
Angus W. Wallace

1 September 2002 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
RNRosenberg Nahum
Rosenberg Nahum
MLM. Levy
M. Levy
MFM. Francis
M. Francis

1 February 2002 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
SSShalom Stahl
Shalom Stahl
RNRosenberg Nahum
Rosenberg Nahum
The branches of the medial antebrachial cutaneous nerve (MACN) are located at the medial site of the elbow. The MACN, especially the posterior branches, may be injured or transected during cubital tunnel surgery or other medial approaches to the elbow. Damage to the nerve can cause a neuroma, which leads to disabling pain and restriction of elbow movement. The initial treatment of the neuroma is nonsurgical, and includes local massage, desensitization, physiotherapy, and systemic medication. If after 6 months of these nonsurgical treatments there is no improvement, surgery is indicated. The authors report their experience with 12 patients treated surgically for painful neuroma by high resection of the proximal end or its implantation into the triceps muscle. After surgery there was a high success rate of pain relief and functional improvement in both elbow movement and handgrip strength.